Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 79,500 shares at $52.13 ($4.2M) on 2012-05-07, disclosed to the SEC on 2012-05-09.
Scheduled sale ($4.2M) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.13 | 54,500 | $2.8M | 67.4% |
| 2 | $55.00 | 25,000 | $1.4M | 32.6% |
| Total | $53.03 avg | 79,500 | $4.2M | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |